fbpx

Year

2019
Lund, Sweden, 19.00 CET, 18 September 2019 – BONESUPPORT HOLDING AB, listed on Nasdaq Stockholm – an emerging leader in orthobiologics for the management of bone voids announced today that health economic data was presented during the EBJIS conference entitled “The economic burden of osteomyelitis in the UK”. Data shows that the number of patient...
SAN DIEGO, Sept. 16, 2019 /PRNewswire/ — Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that two independent review committees completed their planned safety and efficacy assessment of data from 50% of the planned study population enrolled in the Company’s Phase 2 open-label clinical...
SAN DIEGO, Sept. 16, 2019 /PRNewswire/ — Amplyx Pharmaceuticals Inc. a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that it has executed an exclusive worldwide license agreement with Novartis under which Amplyx has acquired the rights to the Phase 2 anti-BK virus (BKV) monoclonal antibody, MAU868,...
Cambridge, UK and Indianapolis, US – 16 September 2019: Acacia Pharma Group plc (the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients, announces that application has been made to Euronext Brussels for the admission of the 192,498 Ordinary Shares of...
Designation Underscores Urgent Need for New Antifungals Targeting Multidrug-Resistant Pathogens SAN DIEGO – Sept. 9, 2019 – Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that the U.S. Food & Drug Administration (FDA) has granted Fast Track designations for both the intravenous (IV) and oral...
In recent years, researchers in a number of countries, including Denmark, have been experimenting with the use of psychedelic substances in the design of drugs for mental disorders. The preliminary results are promising. Just imagine if you could take a psychedelic trip to relieve persistent, severe depression. Or maybe to get rid of it once...
Cambridge, UK and Indianapolis, US – 5 September 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company” or the “Group”), (EURONEXT: ACPH), a pharmaceutical company developing and commercialising hospital products for US and international markets, announces its unaudited interim results for the six-month period ended 30 June 2019. A conference call will take place today at...
Lund, Sweden, 18:00 pm CET, 30 August 2019 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids. During August, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased due to the exercise of warrants. As of 31 August 2019, the number of shares in BONESUPPORT HOLDING AB...
Scientists from Denmark and Japan have peeked inside the engine room of the pumps that maintain the acid level in the stomach. And it was no easy task – the pumps are ultra-small! These pumps – in fact proteins, each measuring only about five millionths of a millimetre – are produced in special cells in...
Lund, Sweden, 10.00 am CET, 21 August 2019 – BONESUPPORT™, listed on Nasdaq Stockholm – an emerging leader in orthobiologics for the management of bone voids, announces that the patient enrollment schedule for the ongoing FORTIFY study is extended. Providing strong clinical evidence in support of its core technology, CERAMENT, is one of the cornerstones...
1 2 3 4 5 6 13

News

Seven research institutions receive DKK 20 million for coronavirus research
1. April 2020
How we handle changes to research projects in light of the coronavirus pandemic
31. March 2020
Lundbeck Foundation gives its first coronavirus grant to trial with a known drug
26. March 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge